FDA approves generic versions of ADHD drug Vyvanse ...Middle East

The Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to treat attention deficit/hyperactivity (ADHD), a decision that comes amid a nationwide shortage of ADHD-treatment drugs.  The newly approved medication can treat both ADHD in patients six years and older and binge-eating disorder (BED) in adults, the FDA said in an announcement.  The FDA said the generic versions of Vyvanse “work in the same way” and have the same benefit and risks as their brand-name counterparts. The approval comes amid the nationwide shortage of Adderall, a drug commonly prescribed to treat ADHD. The FDA first announced the shortage in October, citing an insuff

Hence then, the article about fda approves generic versions of adhd drug vyvanse was published today ( Wednesday 30/08/2023 - 12:32 AM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves generic versions of ADHD drug Vyvanse )

Also on site :

• Human heads displayed at Ecuador tourist beach in warning to gangs
• Nazi salutes and drug cartels: Dutch mercenary recounts service with Kiev’s military
• Macy’s Valley Fair shoppers thwart Rolex watch thieves